Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 dose-response study of gantacurium for tracheal intubation during general anesthesia
2004-004728-11Phase 2Completed
- Sponsor
- Avera Pharmaceuticals
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of gantacurium in None (3 arms), sponsored by Avera Pharmaceuticals. Primary endpoints: Graded intubation score at 60 seconds and Dose-response relationship. Started Feb 2005; status: completed.
02
Drugs
gantacurium
Beyond the preview
Go deeper on 2004-004728-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004728-11.